Physician profile
Jignesh Patel
NPI 1326309733
$1,253.38
in general payments reported to CMS, 2019-2025
14 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $75.07 · 2023: $450 · 2024: $373 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.32 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $386.67 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $196.71 | 2023-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $147.36 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $79.11 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $78.13 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $56.89 | 2024-2025 | |
| Abbvie INC. | $54.82 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $53.39 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Phathom Pharmaceuticals, INC. | $44.21 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.87 | 2022-2025 | Jardiance |
| Amgen INC. | $41.84 | 2023-2025 | Otezla, Repatha, Repatha |
| Merck Sharp & Dohme LLC | $33.46 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Dexcom, INC. | $24.19 | 2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jignesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.